A Study of Filgotinib in Korean Participants With Rheumatoid Arthritis

Clinical trial NCT06625242 · COMPLETED

Trial details

NCT number: NCT06625242
Sponsor: Eisai Korea Inc.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2024-10-22
Primary completion: 2026-01-21
Enrollment: 118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.